Phacilitate Leaders World


Reg Waldeck

Reg Waldeck

Market Access Strategy Leader, Bayer

Reg Waldeck is an Oncology Market Access Strategy Leader at Bayer Pharmaceuticals in the US, where he leads Market Access and related activities for Bayer's prostate cancer franchise and development pipeline. Reg was formerly head of Market Access, Pricing, Health Economics at Celldex Therapeutics Inc., a biotechnology company developing targeted therapeutics in (immuno)-oncology. Prior to this, he was with Bristol-Myers Squibb for 15 years in various functions spanning Marketing, Access, Pricing, and HEOR. Dr. Waldeck has a PhD in Biophysical Chemistry from the University of Sydney, and completed a postdoc in Biophysics at Caltech (Pasadena, CA), as well as post-graduate certificates in Health Economics (Monash University, Australia) and Marketing (University of Connecticut, USA). 

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman